Correspondence to Isabelle J Henskens; i.henskens{at}antoniusziekenhuis.nl Ethics and dissemination Ethical approval was obtained from the Medical Research Ethics Committees United (6 November 2024; ...
Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...
Extended dissection did not improve recurrence-free or overall survival, but it may have a bladder cancer-specific survival benefit possibly because it removes micrometastases. Extended lymph node ...
A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyzes previously unutilized information in ...
We sought to evaluate whether patients with breast cancer who undergo a total mastectomy (TM) can safely forgo a completion axillary lymph node dissection (cALND) in the presence of one to three ...
Following propensity score matching, the comparative results between the two groups remained statistically non-significant. The five-year axillary recurrence-free survival (ARFS) rate was 99.2% for ...
Dr. Ko Un “Clara” Park and Dr. Mylin Torres present the latest evidence-based changes to the SLNB in early-stage breast cancer guideline. They discuss the practice-changing trials that led to the ...
The publication of the INSEMA trial results in The New England Journal of Medicine on December 12, 2024 (5), marks a pivotal moment in the treatment paradigm for early-stage breast cancer. Coupled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results